NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/17/21

Self-diagnostic device designed to assist Avenova customers with management of common lid and lash problems NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on expanding its presence in the eye and skin care market, announ...

NovaBay Pharmaceuticals, Inc. (NBY) Q1 2021 Earnings Conference Call May 06, 2021 04:30 PM ET Company Participants Jody Cain - Investor Relations-LHA Justin Hall - President and Chief Executive Officer Andy Jones - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg...

Over-the counter (“OTC”) Avenova ® revenue topped $1 million for the first time with record unit sales Cash and cash equivalents of $10.5 million as of March 31, 2021 Extending the Avenova product line with complementary products Conf...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three months ended March 31, 2021 after market close on Thursday, May 6, 2021 and will hold an investment community conference call that day at 4:30 p.m. Eastern time. ...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces the availability of its new Warm Eye Compress on Amazon.com and on Avenova.com . This new, reusable heated eye comp...

NovaBay Pharmaceuticals, Inc. (NBY) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Jody Cain – Investor Relations-LHA Justin Hall – President and Chief Executive Officer Andy Jones – Chief Financial Officer Conference Call Participants Jef...

NovaBay (NBY): Q4 GAAP EPS of -$0.04 in-line.Revenue of $1.89M (+11.2% Y/Y) misses by $0.59M.Press Release For further details see: NovaBay EPS in-line, misses on revenue

Avenova ® unit sales set record for second consecutive quarter Net product revenue increased 51% for 2020 Exited 2020 with $12.0 million in cash and equivalents Avenova access expanded to CVS stores and CVS online Conference call begins at ...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces it will report financial results for the three and 12 months ended December 31, 2020 after market close on Thursday, March 25, 2021 and will hold an investment community conference call that day at 4:30 p.m. Eas...

NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova ® for the eye care market and CelleRx ® Clinical Reset™ for the beauty market, announces that management will hold one-on-one investor meetings at the Virt...